• Home
  • Opportunities in the Contemporary Bioscience Industry in the USA & Japan

Opportunities in the Contemporary Bioscience Industry in the USA & Japan

  • 23 Mar 2016
  • 11:30 AM - 1:30 PM (PDT)
  • PSU Business Accelerator, SW Corbett & SW Meade, Portland, OR 97201

Registration

  • Special price includes bento lunchbox.

Registration is closed

Discover how a novel DNA sequencing technology start-up leverages the advantages of research in Silicon Valley and Japan. What challenges are posed by bi-national operations for a young company? How can an Oregon company take advantage of incentives being offered by the Japanese government to encourage trans-Pacific collaboration? What opportunities for business expansion are there, and is the Japanese marketplace a good choice? Is it necessary to find partners, or can you go it alone?

Listen to the discussion and then join in a Q&A session. A delicious, authentic Japanese bento box lunch is provided for all attendees. Also  collect your free Japanese staplers courtesy of PLUS Corporation, and bring your business card for a chance to win a bottle of sake!

Our speakers:

Mr. Yoshiaki Tojo, Chief Executive Director, JETRO San Francisco, & Program Adviser, NEDO.

Director Tojo assumed the position of Chief Executive Director of JETRO’s San Francisco office in August 2014. Immediately prior, he was Director of the Trade Control Policy Division at METI, the Ministry of Economy Trade and Industry, in Tokyo. In April 2011, he joined the New Energy and Industrial Technology Development Organization (NEDO) – the largest R&D management agency in Japan. He has worked at the Organization for Economic Cooperation and Development (OECD) in Paris, France. He has studied at Yale University. He is originally from Kobe in Japan.

Mr. Christopher Pascoe, CPA, CFO, Quantum Biosystems

Chris has more than thirty years of experience in the biotechnology and software industries. He has been the founding CFO for several companies in these areas, and also has experience as COO at two biotechnology companies, most notably at Perlegen Sciences, a genetic analysis and diagnostic testing company based in California. He is a CPA (PricewaterhouseCoopers) and a Chartered Accountant (Deloitte), and brings to Quantum Biosystems his extensive international experience in establishing and managing strong financial and operational practices.

Event Schedule:

11:30 am         Registration and networking

12:00 noon      Presentations begin

1:00 pm           Discussion, Q&A

1:30 pm           Close

How to get there: www.pdx.edu/accelerator/directions

JETRO, or the Japan External Trade Organization, is a government-related organization that works to promote mutual trade and investment between Japan and the rest of the world. Originally established in 1958 to promote Japanese exports abroad, JETRO's core focus in the 21st century has shifted toward promoting foreign direct investment into Japan and helping small to medium size Japanese firms maximize their global export potential.  www.jetro.go.jp/en/jetro

Quantum Biosystems aims to quantum mechanics to the development of innovative single-molecule DNA sequencers. The technology is based on the work of Massimiliano Di Ventra, PhD,  a professor at the University of California, San Diego, and a world-renowned theorist in condensed matter physics. He was the first to propose DNA sequencing by the tunneling concept. His team at UCSD has theoretically shown the feasibility of this fast, inexpensive technique to sequence DNA as it passes through nanopores. The company has headquarters in Tokyo, Japan and Menlo Park, CA and was formed in January of 2013. www.quantumbiosystems.com

An event in partnership with:


Japan-America Society of Oregon is a 501(c) (3) non-profit organization. 900 SW Fifth Avenue, Suite 1810, Portland, OR 97204

Powered by Wild Apricot Membership Software